Mirum Pharmaceuticals, Inc.
MIRM • NASDAQ
Mirum Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Christopher Peetz, with a market cap of $5.6B.
Market Cap$5.6B
Employees278.0
CEOChristopher Peetz
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 6, 2026 · In 1 weekAfter Market Close · Q1 2026
Financials
Mirum Pharmaceuticals, Inc. FAQ
Common questions about Mirum Pharmaceuticals, Inc.
Mirum Pharmaceuticals, Inc. is scheduled to report earnings for Q1 2026 on May 6, 2026 after market close. Analysts estimate revenue of $148.2M.
Mirum Pharmaceuticals, Inc. has approximately 278 employees.